Edwards Lifesciences Corporation (EW) Stock Investment Calculator & Historical Return Analysis
Edwards Lifesciences Corporation is the global leader in patient-focused innovations for structural heart disease and critical care monitoring. The company partners with clinicians to develop innovative technologies in the areas of structural heart disease, including transcatheter aortic heart valve replacement (TAVR), and critical care, focusing on advanced hemodynamic monitoring. Edwards' products are used to treat patients with heart valve diseases and to monitor patients in acute care settings globally. Investors often view Edwards Lifesciences Corporation as a key player in the market, analyzing its long-term potential through various revenue models, brand recognition, and consistent presence in its industry.
This Edwards Lifesciences Corporation stock investment calculator allows you to explore how a hypothetical investment in EW might have performed over time. By adjusting the investment amount and time period, you can visualize potential growth, compare outcomes across different market cycles, and better understand the impact of long-term investing.
What if you invested $1000 in EW on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Understanding Edwards Lifesciences Corporation's Historical Performance
Edwards Lifesciences Corporation's stock performance has historically reflected both broader market trends and company-specific milestones. Like many growth-oriented stocks, EW has experienced periods of growth driven by innovation and market demand.
When analyzing Edwards Lifesciences Corporation's historical returns, it's important to consider:
- Market cycles: Strong bull markets often amplify returns, while recessions can temporarily suppress performance.
- Business model evolution: Changes in revenue strategies and product lines can significantly impact stability.
- Long-term trends: Over extended periods, compounding can play a larger role than short-term price fluctuations.
This calculator helps you see how these factors might have affected an investment depending on when you entered the market.
Historical Annual Returns
Over the past 27 years, Edwards Lifesciences Corporation has delivered an annualized return (CAGR) of +17.2%. Its strongest year was 2014 at +93.2%, and its weakest was 2022 at -41.9%. Overall, the stock finished in the green 21 times out of 27 years.
Annualized
+17.2%
Win Rate
78%
21W - 6L
Best
+93.2%
2014
Worst
-41.9%
2022
Performance Consistency
Edwards Lifesciences Corporation Annual Returns by Year
| Year | Annual Return | Start Price | End Price |
|---|---|---|---|
| 2000 | +7.58% | $1.38 | $1.48 |
| 2001 | +59.02% | $1.45 | $2.30 |
| 2002 | -7.04% | $2.28 | $2.12 |
| 2003 | +17.59% | $2.13 | $2.51 |
| 2004 | +37.81% | $2.49 | $3.44 |
| 2005 | +2.11% | $3.40 | $3.47 |
| 2006 | +13.62% | $3.45 | $3.92 |
| 2007 | -4.07% | $3.99 | $3.83 |
| 2008 | +21.57% | $3.77 | $4.58 |
| 2009 | +55.12% | $4.67 | $7.24 |
| 2010 | +84.84% | $7.29 | $13.47 |
| 2011 | -10.79% | $13.21 | $11.78 |
| 2012 | +25.24% | $12.00 | $15.03 |
| 2013 | -28.63% | $15.36 | $10.96 |
| 2014 | +93.23% | $10.99 | $21.23 |
| 2015 | +23.68% | $21.29 | $26.33 |
| 2016 | +18.85% | $26.28 | $31.23 |
| 2017 | +18.00% | $31.84 | $37.57 |
| 2018 | +37.27% | $37.19 | $51.06 |
| 2019 | +56.32% | $49.75 | $77.76 |
| 2020 | +17.72% | $77.50 | $91.23 |
| 2021 | +45.69% | $88.92 | $129.55 |
| 2022 | -41.87% | $128.34 | $74.61 |
| 2023 | +2.67% | $74.27 | $76.25 |
| 2024 | -2.04% | $75.57 | $74.03 |
| 2025 | +17.44% | $72.59 | $85.25 |
| 2026 | +6.39% | $85.33 | $90.78 |
Historical annual returns for Edwards Lifesciences Corporation. Each year shows the change from that year's first trading day to its last, using split- and dividend-adjusted closing prices. The current year is partial (year-to-date).
Why Use a "What If" Stock Calculator?
Many investors wonder questions such as:
- What if I had invested 5 years ago?
- How does timing affect long-term returns?
- What role does compounding play in stock investments?
A what-if investment calculator answers these questions by turning historical data into practical insights. Rather than focusing on daily price movements, it encourages a long-term perspective, which is especially useful for retirement planning, portfolio comparisons, and financial education.
Key Innovations
- ✓Introduced advanced hemodynamic monitoring technologies that provide clinicians with critical real-time patient data to guide treatment decisions.
- ✓Pioneered and continues to lead the development of transcatheter heart valve therapies, offering less invasive treatment options for patients with heart valve disease.
- ✓Proprietary technology architecture developed by Edwards Lifesciences Corporation to optimize operational performance.
- ✓Integration of advanced data analytics and automation into core operational workflows.
- ✓Strategic R&D investment driving next-generation solution design and market differentiation.
- ✓Expansion of digital transformation initiatives across product engineering and customer delivery.
Business Segments
- Transcatheter Aortic Valve Replacement (TAVR)Develops and manufactures devices for the minimally invasive replacement of the aortic heart valve.
- Surgical Structural HeartOffers a range of products for the surgical repair and replacement of heart valves.
- Critical CareProvides advanced hemodynamic monitoring solutions used to measure a patient's cardiovascular performance in critical care settings.
How to Interpret the Results
The results shown are based on historical performance and are meant for educational and informational purposes only. They do not account for future market conditions, taxes, transaction fees, or individual investment strategies. Past performance does not guarantee future results, but historical analysis can show how an investment behaved across different market cycles.
For best use:
- Compare multiple time ranges to see how outcomes differ
- Use consistent assumptions across different stocks
- Combine this tool with fundamental research and diversification principles